Covidien's ev3 subsidiary asks the Delaware Supreme Court for a new trial over the $175 million in milestones Appriva Medical alleges are owed from a 2002 acquisition.
Covidien (NYSE:COV) subsidiary ev3 wants the Delaware Supreme Court to grant a new trial in a lawsuit over $175 million ev3 allegedly owes its own Appriva Medical acquisition.
The FDA clears the titanium bone wedges made by Integra LifeSciences for use in repairing foot bone fractures.
Integra LifeSciences (NSDQ:IART) said it obtained 510(k) clearance from the FDA for its Integra titanium bone wedges.
The wedges are designed for corrective procedures, such as osteotomies, in treating fractures in foot bones, according to a press release.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Medtech titan Covidien lands regulatory wins in the U.S. and the European Union for its next-generation Puritan Bennett 980 ventilator.
Massachusetts-based Covidien (NYSE:COV) landed European and U.S. regulatory wins for its new Puritan Bennett 980 ventilator.
Covidien closes the $860 million acquisition of Given Imaging and its PillCam capsule endoscope.
Covidien (NYSE:COV) said it closed the buyout of Given Imaging and its PillCam imaging device for about $860 million, net of cash and investments.
Welch Allyn debuts a new Connex clinical surveillance system featuring monitoring technology from Masimo, Covidien and EarlySense.
Covidien wins 510(k) clearance from the FDA for its Endo Gia surgical stapler.
Covidien (NYSE:COV) won 510(k) clearance from the FDA for its Endo Gia surgical stapler.
The Endo Gia, which uses an advanced polymer felt material to provide additional support to fragile tissue, landed Japanese approval in late January.